Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Feb 2022 - Jan 2023
Lobbyists (Full time equivalent)
1 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Indonesia AIDS Coalition (IAC)
EU Transparency Register
862117050128-70 First registered on 29 May 2023
Goals / Remit
Established in 2011, Indonesia AIDS Coalition (IAC) is a community-based organization that focuses its work on fulfilling the rights of People Living with HIV (PLHIV) and key affected populations by encouraging transparency in the HIV response, promoting community participation through community empowerment, and reducing stigma and discrimination towards PLHIVs and KPs. Vision: To achieve an Indonesia without stigma and discrimination by recognizing, fulfilling, and protecting the human rights of PLHIVs and KPs. The rights that are specifically emphasized are the rights to health, education, employment, a decent living, and children's rights. Key Expertise: 1) Community system strengthening; 2) Reducing human rights barriers in access to health; 3) Promoting community financial sustainability through domestic financing; and 4) Improving access to health commodities.
Main EU files targeted
IAC's interest lies in several topics, namely: 1. Promoting an enabling environment for CSOs to be better able to contribute to sustainable development, governance reform, and gender equality in Indonesia. Several ways to achieve this are: 1) Capacity building and organizational strengthening activities; 2) Encouraging CSOs to participate in policy dialogue with national and local authorities, representing and voicing the concerns of vulnerable and marginalized groups, and holding governments to account; and 3) Encouraging CSOs to achieve financial sustainability by accessing new funding sources, including public funding, without diminishing their independence. 2. Access to affordable medicines and vaccines, especially life-saving medicines for HIV-AIDS, TB, and Hepatitis C.
Referring to the interests stated above as well as IAC's experience and core business, IAC generally monitors and engages in Health and International Aid policy themes, such as the EU Global Health Strategy, Compulsory Licensing, and the International Pandemic Accord. We also pay special attention to the ongoing Indonesia-EU Comprehensive Partnership Agreement (CEPA) negotiation process, especially in regard to the IP Chapter and its impact on access to affordable medicines (for HIV-AIDS, TB, and Hepatitis C). In summary, our work is in line with the EU International Strategies, which also align with the Sustainable Development Goals, particularly the development and strengthening of health systems, through capacitating and empowering the community to take part in the improvement of the health system itself.
Furthermore, our work also contributes to gender empowerment and promotes gender equality in all aspects, particularly in reducing gender-based violence and combating discrimination against gender minorities. Specifically, our current and future work will contribute to the EU’s policies, as elaborated below: 1. International Partnership Policies: Gender equality, human development (health and demography, reducing inequalities, social protection, and strengthening health systems), and peace and governance (civil society, democracy, human rights, and fundamental values). 2. Justice and Fundamental Rights Policies: International gender equality, international human rights, EU Charter of Fundamental Rights, and combating discrimination. 3. Public Health Policies and Actions: Health Emergency Preparedness and Response (HERA), international cooperation, health security and infectious diseases, vaccination, improving the health system, improving access to pharmaceutical components, and promoting good health. The work and actions will also be in conjunction with the EU Global Health Strategy as part of the Global Gateway.Address
Head Office
Jl Tebet Dalam IV E No.15, RT/RW 20/01, Tebet Barat, Jakarta Selatan, DKI Jakarta
DKI Jakarta 12810
INDONESIAEU Office
Jl Tebet Dalam IV E No.15, RT/RW 20/01, Tebet Barat, Jakarta Selatan, DKI Jakarta
DKI Jakarta 12810
INDONESIAWebsite
-
People
Total lobbyists declared
4
Employment time Lobbyists 25% 4 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
1. Indonesian Civil Society Coalition for Economic Justice (Masyarakat untuk Keadilan Ekonomi/MKE)
2. The Coalition for Affordable Medicines Indonesia (Koalisi Obat Murah/KOM)
3. People's Health Movement: https://phmovement.org/
4. Make Medicines Affordable Campaign: https://makemedicinesaffordable.org/Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Feb 2022 - Jan 2023
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
7,382,388€
Major funding types in closed year
Grants
Major contributions in closed year
Type Name Amount Contribution ActionAID - PVA 22,266€ Contribution UNAIDS Phase IV 94,730€ Contribution AIDSFONDS Brilliant-ID 113,060€ Contribution the Global Fund 7,152,331€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
The IAC has carried out a number of communication activities (campaigns, publications, etc.) in relation to the I-EU CEPA.
1. The formulation of policy briefs regarding FTA, TRIPS, & I-EU CEPA and their impact on access to affordable medicines. This policy brief has been submitted to the Indonesian Minister of Health; 2. The formulation of an open letter, which can be accessed via: https://igj.or.id/2023/05/09/open-letter-to-eu-commission-drop-trips-plus-provision-on-indonesia-eu-cepa/?lang=en;
3. Networking activities with European CSO partners and audiences with representatives from Left MEPs, as well as advisors to the Committee on International Trade (INTA);
4) Consolidation activities with fellow members of the Indonesian Civil Society Coalition for Economic Justice (Masyarakat untuk Keadilan Ekonomi/MKE) and media briefing activities to respond to the 16th I-EU CEPA negotiation round in Brussels, Belgium; and
5) Audience with the Directorate of Bilateral Negotiations of the Indonesian Ministry of Trade regarding progress with the I-EU CEPA negotiation process. In the latter half of 2023, IAC also conducted hearings with representatives of the European Parliament and the European Union Ambassador to Indonesia.Other activities
None declared
Meetings
Meetings
None declared